Victory Capital Management Inc Sorrento Therapeutics, Inc. Transaction History

Victory Capital Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.74 - $1.83 $170,793 - $422,367	-230,802 Reduced 82.03%	50,555 $44,000
Q3 2022 Nov 02, 2022	BUY	$1.51 - $2.88 $244,805 - $466,914	162,123 Added 135.97%	281,357 $442,000
Q2 2022 Aug 01, 2022	SELL	$1.24 - $2.33 $174,998 - $328,828	-141,128 Reduced 54.2%	119,234 $240,000
Q1 2022 May 04, 2022	BUY	$2.0 - $4.9 $447,204 - $1.1 Million	223,602 Added 608.28%	260,362 $393,000
Q4 2021 Feb 07, 2022	BUY	$4.65 - $7.23 $11,736 - $18,248	2,524 Added 7.37%	36,760 $171,000
Q3 2021 Nov 02, 2021	SELL	$7.41 - $10.99 $120,293 - $178,411	-16,234 Reduced 32.17%	34,236 $261,000
Q2 2021 Aug 03, 2021	BUY	$6.35 - $10.0 $15,227 - $23,980	2,398 Added 4.99%	50,470 $489,000
Q1 2021 May 04, 2021	BUY	$7.03 - $16.51 $6,762 - $15,882	962 Added 2.04%	48,072 $398,000
Q4 2020 Feb 01, 2021	BUY	$5.76 - $11.95 $171,239 - $355,261	29,729 Added 171.04%	47,110 $322,000
Q3 2020 Nov 09, 2020	BUY	$6.17 - $18.82 $107,240 - $327,110	17,381 New	17,381 $194,000

5.48M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.